Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

Evaluation of Apoptosis Induced by Celecoxib Loaded Liposomes in Isolated Rat Hepatocytes

Mojtaba Kalantar 1 , Mohsen Rezaei 1 , 2 , * , Eskandar Moghimipour 3 , Neda Bavarsad 4 , Heibatallah Kalantari 1 , Golnaz Varnaseri 1 and Arash Forouzan 5
Authors Information
1 Department of Pharmacology and Toxicology, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Department of Toxicology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IR Iran
3 Department of Pharmaceutics, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
4 Nanotechnology Research Center, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
5 Department of Emergency, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: August 01, 2015, 10 (3); e25421
  • Published Online: August 30, 2015
  • Article Type: Research Article
  • Received: January 18, 2015
  • Revised: June 10, 2015
  • Accepted: July 12, 2015
  • DOI: 10.17795/jjnpp-25421

To Cite: Kalantar M, Rezaei M, Moghimipour E, Bavarsad N, Kalantari H, et al. Evaluation of Apoptosis Induced by Celecoxib Loaded Liposomes in Isolated Rat Hepatocytes, Jundishapur J Nat Pharm Prod. 2015 ; 10(3):e25421. doi: 10.17795/jjnpp-25421.

Copyright © 2015, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Ferreira AJ, Cemlyn-Jones J, Robalo Cordeiro C. Nanoparticles, nanotechnology and pulmonary nanotoxicology. Rev Port Pneumol. 2013; 19(1): 28-37[DOI][PubMed]
  • 2. Bottini M, Bruckner S, Nika K, Bottini N, Bellucci S, Magrini A, et al. Multi-walled carbon nanotubes induce T lymphocyte apoptosis. Toxicol Lett. 2006; 160(2): 121-6[DOI][PubMed]
  • 3. Aillon KL, Xie Y, El-Gendy N, Berkland CJ, Forrest ML. Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv Drug Deliv Rev. 2009; 61(6): 457-66[DOI][PubMed]
  • 4. Linkov I, Satterstrom FK, Corey LM. Nanotoxicology and nanomedicine: making hard decisions. Nanomedicine. 2008; 4(2): 167-71[DOI][PubMed]
  • 5. Torchilin VP, Lukyanov AN, Gao Z, Papahadjopoulos-Sternberg B. Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs. Proc Natl Acad Sci U S A. 2003; 100(10): 6039-44[DOI][PubMed]
  • 6. El-Ansary A, Al-Daihan S. On the toxicity of therapeutically used nanoparticles: an overview. J Toxicol. 2009; 2009: 754810[DOI][PubMed]
  • 7. Chan VS. Nanomedicine: An unresolved regulatory issue. Regul Toxicol Pharmacol. 2006; 46(3): 218-24[DOI][PubMed]
  • 8. Borm PJ, Muller-Schulte D. Nanoparticles in drug delivery and environmental exposure: same size, same risks? Nanomedicine (Lond). 2006; 1(2): 235-49[DOI][PubMed]
  • 9. Yamakawa N, Suemasu S, Okamoto Y, Tanaka K, Ishihara T, Asano T, et al. Synthesis and biological evaluation of derivatives of 2-{2-fluoro-4-[(2-oxocyclopentyl)methyl]phenyl}propanoic acid: nonsteroidal anti-inflammatory drugs with low gastric ulcerogenic activity. J Med Chem. 2012; 55(11): 5143-50[DOI][PubMed]
  • 10. Fischer SM, Lo HH, Gordon GB, Seibert K, Kelloff G, Lubet RA, et al. Chemopreventive activity of celecoxib, a specific cyclooxygenase‐2 inhibitor, and indomethacin against ultraviolet light–induced skin carcinogenesis. Mol Carcinog. 1999; 25(4): 231-40[DOI]
  • 11. Strillacci A, Griffoni C, Lazzarini G, Valerii MC, Di Molfetta S, Rizzello F, et al. Selective cyclooxygenase-2 silencing mediated by engineered E. coli and RNA interference induces anti-tumour effects in human colon cancer cells. Br J Cancer. 2010; 103(7): 975-86[DOI][PubMed]
  • 12. Thun MJ, Henley SJ, Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst. 2002; 94(4): 252-66[PubMed]
  • 13. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med. 2000; 342(26): 1946-52[DOI][PubMed]
  • 14. Gaosong W, Jilin Y, Fang D, Shengquan Z, Xingrui L. Celecoxib inhibits proliferation and induces apoptosis via cyclooxygenase-2 pathway in human pancreatic carcinoma cells. J Huazhong Univ Sci Technolog Med Sci. 2005; 25(1): 42-4[DOI]
  • 15. Jendrossek V. Targeting apoptosis pathways by Celecoxib in cancer. Cancer Lett. 2013; 332(2): 313-24[DOI][PubMed]
  • 16. Vaish V, Sanyal SN. Role of Sulindac and Celecoxib in chemoprevention of colorectal cancer via intrinsic pathway of apoptosis: exploring NHE-1, intracellular calcium homeostasis and Calpain 9. Biomed Pharmacother. 2012; 66(2): 116-30[DOI][PubMed]
  • 17. Piplani H, Vaish V, Sanyal SN. Dolastatin 15, a mollusk linear peptide, and Celecoxib, a selective cyclooxygenase-2 inhibitor, prevent preneoplastic colonic lesions and induce apoptosis through inhibition of the regulatory transcription factor NF-kappaB and an inflammatory protein, iNOS. Eur J Cancer Prev. 2012; 21(6): 511-22[DOI][PubMed]
  • 18. Hsu AL. The Cyclooxygenase-2 Inhibitor Celecoxib Induces Apoptosis by Blocking Akt Activation in Human Prostate Cancer Cells Independently of Bcl-2. J Biol Chem. 2000; 275(15): 11397-403[DOI]
  • 19. He TC, Chan TA, Vogelstein B, Kinzler KW. PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs. Cell. 1999; 99(3): 335-45[DOI]
  • 20. Herrmann C, Block C, Geisen C, Haas K, Weber C, Winde G, et al. Sulindac sulfide inhibits Ras signaling. Oncogene. 1998; 17(14): 1769-76[DOI]
  • 21. Liu DB, Hu GY, Long GX, Qiu H, Mei Q, Hu GQ. Celecoxib induces apoptosis and cell-cycle arrest in nasopharyngeal carcinoma cell lines via inhibition of STAT3 phosphorylation. Acta Pharmacol Sin. 2012; 33(5): 682-90[DOI][PubMed]
  • 22. Hussain S, Al-Nsour F, Rice AB, Marshburn J, Yingling B, Ji Z, et al. Cerium dioxide nanoparticles induce apoptosis and autophagy in human peripheral blood monocytes. ACS Nano. 2012; 6(7): 5820-9[DOI][PubMed]
  • 23. Kang KW, Chun MK, Kim O, Subedi RK, Ahn SG, Yoon JH, et al. Doxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapy. Nanomedicine. 2010; 6(2): 210-3[DOI][PubMed]
  • 24. Moghimipour E, Handali S. Utilization of thin film method for preparation of celecoxib loaded liposomes. Adv Pharm Bull. 2012; 2(1): 93-8[DOI][PubMed]
  • 25. Azqueta A, Collins AR. The essential comet assay: a comprehensive guide to measuring DNA damage and repair. Arch Toxicol. 2013; 87(6): 949-68[DOI][PubMed]
  • 26. Lorenzo Y, Costa S, Collins AR, Azqueta A. The comet assay, DNA damage, DNA repair and cytotoxicity: hedgehogs are not always dead. Mutagenesis. 2013; 28(4): 427-32[DOI][PubMed]
  • 27. Heibatullah K, Marzieh P, Arefeh I, Ebrahim M. Genotoxicity determinations of coriander drop and extract of Coriander Sativum cultured fibroblast of rat embryo by comet assay. Saudi Pharmaceutical Journal. 2008;
  • 28. Wong V, Szeto Y, Collins AR, Benzie I. The comet assay: a biomonitoring tool for nutraceutical research. Curr Top Nutraceutical Res. 2005; 3(1): 1-14
  • 29. Wood AJ, FitzGerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med. 2001; 345(6): 433-42[DOI][PubMed]
  • 30. Kim SH, Song SH, Kim SG, Chun KS, Lim SY, Na HK, et al. Celecoxib induces apoptosis in cervical cancer cells independent of cyclooxygenase using NF-kappaB as a possible target. J Cancer Res Clin Oncol. 2004; 130(9): 551-60[DOI][PubMed]
  • 31. Piplani H, Rana C, Vaish V, Vaiphei K, Sanyal SN. Dolastatin, along with Celecoxib, stimulates apoptosis by a mechanism involving oxidative stress, membrane potential change and PI3-K/AKT pathway down regulation. Biochim Biophys Acta. 2013; 1830(11): 5142-56[DOI][PubMed]
  • 32. Shureiqi I, Chen D, Lotan R, Yang P, Newman RA, Fischer SM, et al. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells. Cancer Res. 2000; 60(24): 6846-50[PubMed]
  • 33. Butler M. Animal cell culture and technology. 2003;
  • 34. Zhou R, Zhang LZ, Wang RZ. Effect of celecoxib on proliferation, apoptosis, and survivin expression in human glioma cell line U251. Chin J Cancer. 2010; 29(3): 294-9[PubMed]
  • 35. Li WZ, Wang XY, Ding YQ. [Celecoxib induces cell cycle arrest and apoptosis in human tongue squamous carcinoma cell line Tca8113]. Nan Fang Yi Ke Da Xue Xue Bao. 2010; 30(3): 486-9[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments